十年间，澳大利亚的药用大麻处方规模大幅扩大，在线处方服务随之增多，形成商业化市场。1然而，这一增长过程中暴露的监管漏洞引起了医学专家和卫生部门的警觉。澳大利亚卫生执业者管理机构（Ahpra）自2019年以来已对80名执业者采取了监管行动，并发表声明称"一些注册卫生执业者优先考虑利润而非患者安全"。1
专业医学组织对现有处方实践提出了严重关切。1皇家澳大利亚全科医生学院呼吁改革监管框架，加强处方保障。1医学专家指出，当代大麻产品的效力已大幅增长——Matthew Large教授表示，1970年代非法大麻的THC浓度仅为2-5%，而现在可达35%。1这使得高THC产品用于焦虑、失眠等病症的安全性成为关键问题，许多专家质疑患者是否充分了解相关风险。1
澳大利亚注册治疗品数据库（ARTG）仅列出两种大麻药物，占不到1%。1一些在线处方服务提供商的营销语言也引发了争议。1例如，Medicinal Organic Cannabis Australia（MOCA）网站曾声称其产品"获得治疗品管理局（TGA）批准"，后来修正了这一表述。1
A decade after Australia legalized medicinal cannabis, the prescription landscape has transformed into a commercial marketplace marked by growing concerns over regulatory oversight and marketing practices.1 The Australian Register of Therapeutic Goods (ARTG) lists only two cannabis medications, representing less than 1% of products prescribed in the country, yet online prescription services have proliferated.1 Meanwhile, the health regulator Ahpra has taken action against 80 registered practitioners since 2019 for issues related to their cannabis prescribing.1
Medical experts have raised alarm over the potency and clinical justification of many prescriptions. Professor Matthew Large noted that illicit cannabis in the 1970s contained 2-5% THC, whereas products available today can reach 35% concentration.1 High-THC formulations are being prescribed for conditions including anxiety and insomnia, yet concerns persist about patient safety and whether practitioners are adequately informing patients of risks.1 The Royal Australian College of General Practitioners has called for regulatory reforms to strengthen prescribing safeguards.1
Misleading marketing has also drawn scrutiny. Medicinal Organic Cannabis Australia (MOCA) previously claimed its products were "approved by the Therapeutic Goods Administration" on its website before correcting the statement.1 Ahpra issued a statement asserting that "some registered health practitioners are prioritizing profit over patient safety," highlighting tensions between commercial interests and professional standards in a market that remains largely unregistered and loosely supervised.1
评论
还没有评论，欢迎留下第一条。